SpectraCure AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	13.53	18.27	56.95	93.18	129.69
Cash & Short-Term Investments	13.53	18.27	56.95	93.18	129.69
Cash Growth	-25.99%	-67.91%	-38.88%	-28.15%	-17.52%
Accounts Receivable	0.6	0.33	0.18	0.15	0.19
Other Receivables	1.09	1.2	0.84	0.59	0.5
Total Trade Receivables	1.69	1.53	1.02	0.74	0.69
Other Current Assets	1.01	2.45	0.78	0.43	0.41
Total Current Assets	16.22	22.25	58.75	94.34	130.8
Net Property, Plant & Equipment	3.05	5.4	6.95	3.96	6.18
Other Intangible Assets	85.2	93.35	78.42	62.87	53.52
Long-Term Investments	-	-	0.69	1.23	0
Other Long-Term Assets	0	0.01	0.02	0.02	0.02
Total Assets	104.47	121	144.83	162.42	190.52
Accounts Payable	1.71	3.32	1.04	1.61	1.83
Accrued Expenses	6	5.38	6.9	7.14	7.29
Current Portion of Leases	2.57	2.54	-	2.43	-
Other Current Liabilities	0.4	0.31	0.33	0.68	0.82
Total Current Liabilities	10.67	11.54	10.58	11.85	12.35
Long-Term Leases	0.22	2.6	6.72	0.27	4.9
Other Long-Term Liabilities	0.03	0	-	-	-
Total Long-Term Liabilities	0.22	2.6	4.4	0.27	2.49
Total Liabilities	10.92	14.15	14.98	12.12	14.84
Common Stock	40.97	9.71	9.71	9.71	9.71
Additional Paid-in Capital	268.03	258.01	258.01	258.01	258.01
Retained Earnings	-215.45	-160.87	-137.87	-117.43	-92.05
Shareholders' Equity	93.55	106.86	129.86	150.3	175.68
Total Liabilities & Equity	104.47	121	144.83	162.42	190.52
Total Debt	2.79	5.15	6.72	2.7	4.9
Net Cash (Debt)	10.74	13.13	50.23	90.48	124.79
Net Cash Growth	-18.23%	-73.86%	-44.48%	-27.49%	-17.84%
Net Cash Per Share	0.04	0.10	0.52	0.93	1.28
Book Value	93.55	106.86	129.86	150.3	175.68
Book Value Per Share	0.33	0.77	1.34	1.55	1.81
Tangible Book Value	8.36	13.51	51.44	87.43	122.15
Tangible Book Value Per Share	0.03	0.10	0.53	0.90	1.26